投資評等
最後更新日期：2024/11/24
升級(Upgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2011/8/18 | Standpoint Research | Hold >> Buy | 18 |
| 2010/4/27 | Oppenheimer | Perform >> Outperform | 22 |
| 2009/12/29 | Barrington Research | Mkt Perform >> Outperform | 30 |
| 2004/12/13 | FTN Midwest | Neutral->Buy | |
| 2003/9/30 | Morgan Stanley | Equal-weight -> Overweight | 48 |
| 2003/5/11 | Goldman Sachs | Underperform -> In-Line | |
| 2002/11/19 | Salomon Smth Brny | Underperform -> Rn-line | 48 |
| 2002/7/24 | Morgan Stanley | Equal-weight -> Overweight | 53 |
降級(Downgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->降級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2012/12/19 | Compass Point | Buy >> Neutral | $18.50 >> $19.50 |
| 2011/12/27 | Standpoint Research | Buy >> Hold | |
| 2010/9/8 | Oppenheimer | Outperform >> Perform | |
| 2010/7/8 | Barrington Research | Outperform >> Mkt Perform | |
| 2010/2/22 | Oppenheimer | Outperform >> Perform | |
| 2004/12/21 | Morgan Stanley | Equal-weight->Underweight | |
| 2004/4/1 | Goldman Sachs | In-Line->Underperform | |
| 2004/2/25 | Barrington Research | Outperform->Mkt Perform | |
| 2003/12/3 | Morgan Stanley | Overweight->Equal-weight | $54 |
| 2003/4/3 | Goldman Sachs | In-Line -> Underperform | |
| 2002/11/8 | Salomon Smth Brny | Outperform -> Underperform | 60 |
首次予以評等(Coverage Initiated)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 目標股價 |
| 2011/2/15 | Standpoint Research | Buy | 18 |
| 2011/1/26 | Northland Securities | Outperform | 20 |
| 2009/3/20 | Fox Pitt | In Line | 21 |
| 2006/11/15 | CIBC Wrld Mkts | Sector Perform | |
| 2005/4/21 | UBS | Buy | 64 |
| 2005/1/7 | Banc of America Sec | Sell | 42 |
| 2004/4/5 | FTN Midwest | Neutral | |
| 2004/4/2 | Thomas Weisel | Peer Perform | |
恢復投資評等(Coverage Resumed)
| 日期/Date | 券商/Brokerage Firm | 恢復評等後等級/Resumed Rating | 目標股價Target |
| 查無資料 | | | |
重申相同投資評等(Coverage Reiterated)
| 日期/Date | 券商
Brokerage Firm | 重申相同投資評等
Reiterated Rating | 新目標價
New Target |
| 2013/6/7 | Oppenheimer | Outperform | $29 >> $32 |
| 2008/12/18 | Oppenheimer | Outperform | |
| 2004/11/24 | Morgan Stanley | Equal-weight | 47 |
| 2003/8/27 | Barrington Research | Outperform | 55 |
| 2003/6/12 | Barrington Research | Outperform | |
| 2003/6/5 | Barrington Research | Outperform | 50 |
| 2002/12/3 | Barrington Research | Outperform | |
| 2002/11/27 | Morgan Stanley | Overweight | |
| 2002/11/8 | Barrington Research | Outperform | |
| 2002/8/29 | Barrington Research | Strong Buy | |